Flynn: Eli Lilly could capture a significant part of a $100 billion market with Zepbound.
Terence Flynn, Biotech Analyst at Morgan Stanley, discusses Eli Lilly's recent stock boost and its designation as Morgan ...
Eli Lilly's obesity drug gets Medicare coverage for sleep apnea
Eli Lilly's obesity drug Zepbound can now be covered by government-backed Medicare insurance plans for use in sleep apnea, ...
Eli Lilly and Company to set-up global capability centre in Hyderabad, to recruit over 1,000 skilled workers
The company said that it would be recruiting more than a 1,000 highly-skilled team members to strengthen its digital strategy ...
Eli Lilly to launch new capability centre in Hyderabad, hiring over 1,000 skilled professionals
Eli Lilly establishes new global capability centre in Hyderabad, recruiting over 1,000 skilled team members for digital ...
ndtvprofit2h
Eli Lilly To Create New Global Capability Centre In Hyderabad, Hire 1,000 People
The company further said it plans to employ around 1,000 to 1,500 highly-skilled professionals including technology engineers ...
Eli Lilly & Co. stock outperforms competitors on strong trading day
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Medicare Expands Coverage of Eli Lilly’s Weight-Loss Drug
Eli Lilly’s popular anti-obesity drug Zepbound could get a sales boost after the U.S. Medicare program decided to pay for its use to treat sleep apnea. The Centers f ...
Eli Lilly's Options: A Look at What the Big Money is Thinking
Investors with a lot of money to spend have taken a bullish stance on Eli Lilly LLY. And retail traders should know. We ...
STAT2d
Eli Lilly seeks to join lawsuit on compounded drugs
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.